• Food
  • Fitness
  • Wellness
  • Parenting
  • Vital Signs
Edition
  • U.S.
  • International
  • Arabic
  • Español
  • Food
  • Fitness
  • Wellness
  • Parenting
  • Vital Signs
Edition
  • U.S.
  • International
  • Arabic
  • Español
  • World
    • Africa
    • Americas
    • Asia
    • Australia
    • China
    • Europe
    • India
    • Middle East
    • United Kingdom
  • US Politics
    • 2020 Election
    • Facts First
    • Election 101
  • Business
    • Markets
    • Tech
    • Media
    • Success
    • Perspectives
    • Videos
  • Health
    • Food
    • Fitness
    • Wellness
    • Parenting
    • Vital Signs
  • Entertainment
    • Stars
    • Screen
    • Binge
    • Culture
    • Media
  • Tech
    • Innovate
    • Gadget
    • Foreseeable Future
    • Mission: Ahead
    • Upstarts
    • Work Transformed
    • Innovative Cities
  • Style
    • Arts
    • Design
    • Fashion
    • Architecture
    • Luxury
    • Beauty
    • Video
  • Travel
    • Destinations
    • Food and Drink
    • Stay
    • News
    • Videos
  • Sports
    • Football
    • Tennis
    • Equestrian
    • Golf
    • Skiing
    • Horse Racing
    • Motorsport
    • Formula E
    • Esports
  • Videos
    • Live TV
    • Digital Studios
    • CNN Films
    • HLN
    • TV Schedule
    • TV Shows A-Z
    • CNNVR
  • Features
    • Call to Earth
    • Freedom Project
    • Impact Your World
    • Inside Africa
    • 2 Degrees
    • CNN Heroes
    • All Features
  • More
    • Photos
    • Longform
    • Investigations
    • CNN Profiles
    • CNN Leadership
    • CNN Newsletters
    • Work for CNN
  • Weather
    • Climate
    • Storm Tracker
    • Wildfire Tracker
    • Video
Follow CNN
  • In this undated photo provided by Johnson & Johnson in September 2020, a woman receives an injection during phase 3 testing for the Janssen Pharmaceutical-Johnson & Johnson vaccine in the United States. On Friday, Oct. 2, 2020, a U.S. advisory panel made recommendations for who should be first in line to get COVID-19 vaccine, including a plea for special efforts by states and cities to get the shots to low-income minority groups. (Johnson & Johnson via AP)

    A week after Covid-19 vaccine trial goes on pause, Johnson & Johnson and FDA won't reveal critical details

  • It took AstraZeneca researchers 1 month to get vaccine trial data to FDA, source tells CNN

  • Eli Lilly pauses trial of its monoclonal antibody to treat coronavirus because of illness

  • As coronavirus cases rise, Fauci says public health measures are the way to slow spread